"Global Enteric Disease Testing Market Overview:
Global Enteric Disease Testing Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Enteric Disease Testing Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Enteric Disease Testing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Enteric Disease Testing Market:
The Enteric Disease Testing Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Enteric Disease Testing Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Enteric Disease Testing Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Enteric Disease Testing market has been segmented into:
E. coli Infection
Salmonellosis
Campylobacteriosis
Rotavirus Infection
Cryptosporidiosis
Norovirus Infection
Cholera
C. difficile
H. pylori
Amebiasis
Shigellosis
By Application, Enteric Disease Testing market has been segmented into:
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Enteric Disease Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Enteric Disease Testing market.
Top Key Players Covered in Enteric Disease Testing market are:
Alereinc.
Becton Dickinson & Company
Biomericainc.
bioMerieux
Bio-Rad
Cepheid
Coris BioConcept
DiaSorin
Meridian Bioscienceinc.
Quest Diagnostics
Trinity Biotech
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Enteric Disease Testing Market by Type
4.1 Enteric Disease Testing Market Snapshot and Growth Engine
4.2 Enteric Disease Testing Market Overview
4.3 E. coli Infection
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 E. coli Infection: Geographic Segmentation Analysis
4.4 Salmonellosis
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Salmonellosis: Geographic Segmentation Analysis
4.5 Campylobacteriosis
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Campylobacteriosis: Geographic Segmentation Analysis
4.6 Rotavirus Infection
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Rotavirus Infection: Geographic Segmentation Analysis
4.7 Cryptosporidiosis
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Cryptosporidiosis: Geographic Segmentation Analysis
4.8 Norovirus Infection
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 Norovirus Infection: Geographic Segmentation Analysis
4.9 Cholera
4.9.1 Introduction and Market Overview
4.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.9.3 Key Market Trends, Growth Factors and Opportunities
4.9.4 Cholera: Geographic Segmentation Analysis
4.10 C. difficile
4.10.1 Introduction and Market Overview
4.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.10.3 Key Market Trends, Growth Factors and Opportunities
4.10.4 C. difficile: Geographic Segmentation Analysis
4.11 H. pylori
4.11.1 Introduction and Market Overview
4.11.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.11.3 Key Market Trends, Growth Factors and Opportunities
4.11.4 H. pylori: Geographic Segmentation Analysis
4.12 Amebiasis
4.12.1 Introduction and Market Overview
4.12.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.12.3 Key Market Trends, Growth Factors and Opportunities
4.12.4 Amebiasis: Geographic Segmentation Analysis
4.13 Shigellosis
4.13.1 Introduction and Market Overview
4.13.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.13.3 Key Market Trends, Growth Factors and Opportunities
4.13.4 Shigellosis: Geographic Segmentation Analysis
Chapter 5: Enteric Disease Testing Market by Application
5.1 Enteric Disease Testing Market Snapshot and Growth Engine
5.2 Enteric Disease Testing Market Overview
5.3 North America
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 North America: Geographic Segmentation Analysis
5.4 Latin America
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Latin America: Geographic Segmentation Analysis
5.5 Europe
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Europe: Geographic Segmentation Analysis
5.6 Asia Pacific
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Asia Pacific: Geographic Segmentation Analysis
5.7 Middle East & Africa
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Middle East & Africa: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Enteric Disease Testing Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ALEREINC.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 BECTON DICKINSON & COMPANY
6.4 BIOMERICAINC.
6.5 BIOMERIEUX
6.6 BIO-RAD
6.7 CEPHEID
6.8 CORIS BIOCONCEPT
6.9 DIASORIN
6.10 MERIDIAN BIOSCIENCEINC.
6.11 QUEST DIAGNOSTICS
6.12 AND TRINITY BIOTECH
Chapter 7: Global Enteric Disease Testing Market By Region
7.1 Overview
7.2. North America Enteric Disease Testing Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 E. coli Infection
7.2.4.2 Salmonellosis
7.2.4.3 Campylobacteriosis
7.2.4.4 Rotavirus Infection
7.2.4.5 Cryptosporidiosis
7.2.4.6 Norovirus Infection
7.2.4.7 Cholera
7.2.4.8 C. difficile
7.2.4.9 H. pylori
7.2.4.10 Amebiasis
7.2.4.11 Shigellosis
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 North America
7.2.5.2 Latin America
7.2.5.3 Europe
7.2.5.4 Asia Pacific
7.2.5.5 Middle East & Africa
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Enteric Disease Testing Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 E. coli Infection
7.3.4.2 Salmonellosis
7.3.4.3 Campylobacteriosis
7.3.4.4 Rotavirus Infection
7.3.4.5 Cryptosporidiosis
7.3.4.6 Norovirus Infection
7.3.4.7 Cholera
7.3.4.8 C. difficile
7.3.4.9 H. pylori
7.3.4.10 Amebiasis
7.3.4.11 Shigellosis
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 North America
7.3.5.2 Latin America
7.3.5.3 Europe
7.3.5.4 Asia Pacific
7.3.5.5 Middle East & Africa
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Enteric Disease Testing Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 E. coli Infection
7.4.4.2 Salmonellosis
7.4.4.3 Campylobacteriosis
7.4.4.4 Rotavirus Infection
7.4.4.5 Cryptosporidiosis
7.4.4.6 Norovirus Infection
7.4.4.7 Cholera
7.4.4.8 C. difficile
7.4.4.9 H. pylori
7.4.4.10 Amebiasis
7.4.4.11 Shigellosis
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 North America
7.4.5.2 Latin America
7.4.5.3 Europe
7.4.5.4 Asia Pacific
7.4.5.5 Middle East & Africa
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Enteric Disease Testing Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 E. coli Infection
7.5.4.2 Salmonellosis
7.5.4.3 Campylobacteriosis
7.5.4.4 Rotavirus Infection
7.5.4.5 Cryptosporidiosis
7.5.4.6 Norovirus Infection
7.5.4.7 Cholera
7.5.4.8 C. difficile
7.5.4.9 H. pylori
7.5.4.10 Amebiasis
7.5.4.11 Shigellosis
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 North America
7.5.5.2 Latin America
7.5.5.3 Europe
7.5.5.4 Asia Pacific
7.5.5.5 Middle East & Africa
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Enteric Disease Testing Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 E. coli Infection
7.6.4.2 Salmonellosis
7.6.4.3 Campylobacteriosis
7.6.4.4 Rotavirus Infection
7.6.4.5 Cryptosporidiosis
7.6.4.6 Norovirus Infection
7.6.4.7 Cholera
7.6.4.8 C. difficile
7.6.4.9 H. pylori
7.6.4.10 Amebiasis
7.6.4.11 Shigellosis
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 North America
7.6.5.2 Latin America
7.6.5.3 Europe
7.6.5.4 Asia Pacific
7.6.5.5 Middle East & Africa
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Enteric Disease Testing Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 E. coli Infection
7.7.4.2 Salmonellosis
7.7.4.3 Campylobacteriosis
7.7.4.4 Rotavirus Infection
7.7.4.5 Cryptosporidiosis
7.7.4.6 Norovirus Infection
7.7.4.7 Cholera
7.7.4.8 C. difficile
7.7.4.9 H. pylori
7.7.4.10 Amebiasis
7.7.4.11 Shigellosis
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 North America
7.7.5.2 Latin America
7.7.5.3 Europe
7.7.5.4 Asia Pacific
7.7.5.5 Middle East & Africa
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Enteric Disease Testing Scope:
|
Report Data
|
Enteric Disease Testing Market
|
|
Enteric Disease Testing Market Size in 2025
|
USD XX million
|
|
Enteric Disease Testing CAGR 2025 - 2032
|
XX%
|
|
Enteric Disease Testing Base Year
|
2024
|
|
Enteric Disease Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Alereinc., Becton Dickinson & Company, Biomericainc., bioMerieux, Bio-Rad, Cepheid, Coris BioConcept, DiaSorin, Meridian Bioscienceinc., Quest Diagnostics, and Trinity Biotech.
|
|
Key Segments
|
By Type
E. coli Infection
Salmonellosis
Campylobacteriosis
Rotavirus Infection
Cryptosporidiosis
Norovirus Infection
Cholera
C. difficile
H. pylori
Amebiasis
Shigellosis
By Applications
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
|
